Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
93 Additionally, tirzepatide, a dual GIP/GLP-1 receptor agonist, has gained prominence following USFDA approval in 2023 for weight management in adults with obesity or overweight and has demonstrated robust efficacy in RCTs
In the pooled SURPASS trials, the adjusted mean percent change from baseline in UACR for tirzepatide 5, 10, and 15 mg compared with all comparators was minus 19.3%, minus 22.0%, and minus 26.3% respectively at week 40 to 42
Product quality, certifications, and proper dosage matter more than fear-based myths
Specifications First available: 07/2020 Shipping weight: 0.12 kg Product code: NOW-08062 UPC: 733739080622 Package quantity: 59 ml Dimensions: 14 x 4.1 x 4.1 cm , 0.12 kg Suggested use Other ingredients Warnings For external use only
US$ 24.80
US$ 21.19
US$ 29.35
US$ 25.68
US$ 20.50
